{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "29882956", "DateCompleted": {"Year": "2019", "Month": "08", "Day": "26"}, "DateRevised": {"Year": "2023", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "08", "Day": "08"}], "Language": ["eng"], "ELocationID": ["10.1002/cpt.1132"], "Journal": {"ISSN": "1532-6535", "JournalIssue": {"Volume": "104", "Issue": "3", "PubDate": {"Year": "2018", "Month": "Sep"}}, "Title": "Clinical pharmacology and therapeutics", "ISOAbbreviation": "Clin Pharmacol Ther"}, "ArticleTitle": "A Tiered Approach for the Evaluation of the Safety of Botanicals Used as Dietary Supplements: An Industry Strategy.", "Pagination": {"StartPage": "446", "EndPage": "457", "MedlinePgn": "446-457"}, "Abstract": {"AbstractText": ["Exposure to botanicals in dietary supplements is increasing across many geographies; with increased expectations from consumers, regulators, and industry stewards centered on quality and safety of these products. We present a tiered approach to assess the safety of botanicals, and an in silico decision tree to address toxicity data gaps. Tier 1 describes a Threshold of Toxicologic Concern (TTC) approach that can be used to assess the safety of conceptual levels of botanicals. Tier 2 is an approach to document a history of safe human use for botanical exposures higher than the TTC. An assessment of botanical-drug interaction (BDI) may also be necessary at this stage. Tier 3 involves botanical chemical constituent identification and safety assessment and the in silico approach as needed. Our novel approaches to identify potential hazards and establish safe human use levels for botanicals is cost and time efficient and minimizes reliance on animal testing."], "CopyrightInformation": "\u00a9 2018 The Authors Clinical Pharmacology & Therapeutics published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Procter and Gamble Company, Mason Business Center, Cincinnati, Ohio, USA."}], "LastName": "Roe", "ForeName": "Amy L", "Initials": "AL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Procter and Gamble Company, Mason Business Center, Cincinnati, Ohio, USA."}], "LastName": "McMillan", "ForeName": "Donna A", "Initials": "DA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Procter and Gamble Technical Centres Ltd, Greater London Innovation Centre, Egham, UK."}], "LastName": "Mahony", "ForeName": "Catherine", "Initials": "C"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Clin Pharmacol Ther", "NlmUniqueID": "0372741", "ISSNLinking": "0009-9236"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Preparations"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["standards"], "DescriptorName": "Consumer Product Safety"}, {"QualifierName": ["adverse effects", "standards"], "DescriptorName": "Dietary Supplements"}, {"QualifierName": ["standards"], "DescriptorName": "Drug Industry"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["standards"], "DescriptorName": "Patient Safety"}, {"QualifierName": ["adverse effects", "standards"], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["adverse effects", "standards"], "DescriptorName": "Plant Preparations"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Quality Control"}, {"QualifierName": [], "DescriptorName": "Risk Assessment"}, {"QualifierName": ["standards"], "DescriptorName": "Toxicity Tests"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Smith, T. , Kawa, K. , Eckl, V. , Morton, C. & Stredney, R. Herbal supplement sales in US increase 7.7% in 2016. Herbalgram 115, 56\u201365 (2017)."}, {"Citation": "\nCouncil for Responsible Nutrition\n. CRN 2017 Annual Survey on Dietary Supplements (Council for Responsible Nutrition, Washington, DC). < http://www.crnusa.org/survey >."}, {"Citation": "Agbabiaka, T. , Wider, B. , Watson, L. & Goodman, C. Concurrent use of prescription drugs and herbal medicinal products in older adults: a systematic review. Drug Aging 34, 891\u2013905 (2017).", "ArticleIdList": ["PMC5730633", "29196903"]}, {"Citation": "Fryar, C. , Gu, Q. & Ogden, C. Anthropometric reference data for children and adults: United States, 2007\u20132010. Vital. Health Stat. 11, 1\u201348 (2012).", "ArticleIdList": ["25204692"]}, {"Citation": "Bailey, R. , Gahche, J. , Thomas, P. & Dwyer, J. Why US children use dietary supplements. Pediatr. Res. 74, 737\u2013741 (2013).", "ArticleIdList": ["PMC3873849", "24002333"]}, {"Citation": "Kantor, E.D. , Rehm, C.D. , Du, M.M. , White, E. & Giovannucci, E.L. Trends in dietary supplement use among US adults from 1999\u20132012. JAMA 316, 1464\u20131474 (2016).", "ArticleIdList": ["PMC5540241", "27727382"]}, {"Citation": "Dwyer, J. , Coates, P. & Smith, M. Dietary supplements: regulatory challenges and research resources. Nutrients 10, 1\u201324 (2018).", "ArticleIdList": ["PMC5793269", "29300341"]}, {"Citation": "Blackburn, K. , Stickney, J. , Carlson\u2010Lynch, H. , McGinnis, P. , Chappell, L. & Felter, S. Application of the threshold of toxicological concern approach to ingredients in personal and household care products. Regul. Toxicol. Pharmacol. 43, 249\u2013259 (2005).", "ArticleIdList": ["16213074"]}, {"Citation": "Kroes, R. , Kleiner, J. & Renwich, A. Structure\u2010based 2005. The threshold of toxicological concern concept in risk assessment. Toxicol. Sci. 86, 226\u2013230 (2005).", "ArticleIdList": ["15829616"]}, {"Citation": "Munro, I.C. Safety assessment procedures for indirect food\u2010additives\u2014an overview. Regul. Toxicol. Pharmacol. 12, 2\u201312 (1990).", "ArticleIdList": ["2217916"]}, {"Citation": "Munro, I. , Ford, R. , Kennepohl, E. & Sprenger, J. Correlation of structural class with no\u2010observed\u2010effect levels: a proposal for establishing a threshold of concern. Food Chem. Toxicol. 34, 829\u2013867 (1996).", "ArticleIdList": ["8972878"]}, {"Citation": "Kroes, R. et al Structure\u2010based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet. Food Chem. Toxicol. 42, 65\u201383 (2004).", "ArticleIdList": ["14630131"]}, {"Citation": "European Food Safety Authority (EFSA) . Guidance on safety assessment of botanicals and botanical preparations intended for\u00a0use as ingredients in food supplements. EFSA J. 7, 1249 (2009)."}, {"Citation": "McMillan, D. , Kosemund, K. , Mahony, C. , Huber, M. & Bowtell, P. Threshold of toxicological concern (TTC) for botanicals\u2010data analysis to substantiate and extend the TTC approach to botanicals. Toxicol. Suppl. Toxicol. Sci. 150, PS1831 (2017).", "ArticleIdList": ["32058013"]}, {"Citation": "\nResearch Institute for Fragrance Material (RIFM)\n. The RIFM Database 2018. < http://www.rifm.org/rifm-science-database.php#.WvCEmvnwbDc >."}, {"Citation": "\nFEMA (2018). < https://www.femaflavor.org/ >."}, {"Citation": "\nU.S. Food and Drug Administration\n. GRAS Notices. < https://www.accessdata.fda.gov/scripts/fdcc/?set=GRASNotices >."}, {"Citation": "\nU.S. Food and Drug Administration\n. Everything Added to Food in the United States (EAFUS). < https://www.accessdata.fda.gov/scripts/fcn/fcnNavigation.cfm?rpt=eafusListing >."}, {"Citation": "Institute of Medicine and National Research Council . Dietary Supplements: A Framework for Evaluating Safety (The National Academies Press, Washington, DC, 2005).", "ArticleIdList": ["25009855"]}, {"Citation": "Lee, M. The history of Ephedra (ma\u2010huang). J. R. Coll. Physicians Edinb. 41, 78\u201384 (2011).", "ArticleIdList": ["21365072"]}, {"Citation": "European Parliament . Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws\u00a0of\u00a0the Member States relating to cosmetic products (Text with EEA\u00a0relevance). In: Council of the European Union, editor (2003)."}, {"Citation": "Farina, E.K. , Austin, K.G. & Lieberman, H.R. Concomitant dietary supplement and prescription medication use is prevalent among US adults with doctor\u2010informed medical conditions. J. Acad. Nutr. Diet. 114, 1784 (2014).", "ArticleIdList": ["24703929"]}, {"Citation": "Frank, A. & Unger, M. Analysis of frankincense from various Boswellia species with inhibitory activity on human drug metabolising cytochrome P450 enzymes using liquid chromatography mass spectrometry after automated on\u2010line extraction. J. Chromatogr. A 1112, 255\u2013262 (2006).", "ArticleIdList": ["16364338"]}, {"Citation": "Iwata . Identification and characterization mass spectrometry after automated on\u2010line extraction."}, {"Citation": "Brantley, S. , Argikar, A. , Lin, Y. , Nagar, S. & Paine, M. Herb\u2010drug interactions: challenges and opportunities for improved predictions. Drug Metab. Dispos. 42, 301\u2013317 (2013).", "ArticleIdList": ["PMC3935140", "24335390"]}, {"Citation": "Sprouse, A. & van Breemen, R. Pharmacokinetic interactions between drugs and botanical dietary supplements. Drug Metab. Dispos. 44, 162\u2013171 (2016).", "ArticleIdList": ["PMC4727115", "26438626"]}, {"Citation": "Roe, A. Assessing potential herb\u2010drug interactions in the use of herbal dietary supplements: need for a common framework approach. Herbalgram 12, 40\u201343 (2015)."}, {"Citation": "Roe, A. , Paine, M. , Gurley, B. , Brouwer, K. , Jordan, S. & Griffiths, J. Assessing natural product\u2010drug interactions: an end\u2010to\u2010end safety framework. Regul. Toxicol. Pharmacol. 76, 1\u20136 (2016).", "ArticleIdList": ["26776752"]}, {"Citation": "Barr, J. , Jones, J. , Oberlies, N. & Paine, M.F. Inhibition of human aldehyde oxidase activity by diet\u2010derived constituents: structural influence, enzyme\u2010ligand interactions, and clinical relevance. Drug Metab. Dispos. 43, 34\u201341 (2015).", "ArticleIdList": ["PMC4279085", "25326286"]}, {"Citation": "\nEuropean Medicines Agency\n. Herbal medicines for human use. < http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/herbal_search.jsp&mid=WC0b01ac058001fa1d >. Accessed 28 March 2018."}, {"Citation": "\nU.S. Food and Drug Administration\n. In vitro metabolism\u2010 and transporter\u2010mediated drug\u2010drug interaction studies: Guidance for industry. < https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM581965.pdf > (2017)."}, {"Citation": "Korzekwa, K. , Nagar, S. , Tucker, J. , Weiskitcher, E. , Bhoopathy, S. & Hidalgo, I. Models to predict unbound intracellular drug concentrations in the presence of transporters. Drug Metab. Dispos. 40, 865\u2013876 (2012).", "ArticleIdList": ["22279052"]}, {"Citation": "Jackson, J. et al Prediction of clinically relevant herb\u2010drug clearance interactions using sandwich\u2010cultured human hepatocytes: Schisandra spp. case study. Drug Metab. Dispos. 45, 1019\u20131026 (2017).", "ArticleIdList": ["28698304"]}, {"Citation": "Little, J. , Marsman, D. , Baker, T. & Mahony, C. In silico approach to safety of botanical dietary supplement ingredients utilizing constituent\u2010level characterization. Food Chem. Toxicol. 107, 418\u2013429 (2017).", "ArticleIdList": ["28698155"]}, {"Citation": "Wu, S. , Blackburn, K. , Amburgey, J. , Jaworska, J. & Federle, T. A framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR\u2010based toxicology assessments. Regul. Toxicol. Pharmacol. 56, 67\u201381 (2010).", "ArticleIdList": ["19770017"]}, {"Citation": "Blackburn, K. , Bjerke, D. , Daston, G. , Felter, S. , Mahony, C. & Naciff, J. Case studies to test: a framework for using structural, reactivity, metabolic and physicochemical similarity to evaluate the suitability of analogs for SAR\u2010based toxicological assessments. Regul. Toxicol. Pharmacol. 60, 120\u2013135 (2011).", "ArticleIdList": ["21420459"]}, {"Citation": "Wu, S.D. et al Framework for identifying chemicals with structural features associated with the potential to act as developmental or reproductive toxicants. Chem. Res. Toxicol. 26, 1840\u20131861 (2013).", "ArticleIdList": ["24206190"]}, {"Citation": "Picciano, M. & Mcgurie, M. Use of dietary supplements by pregnant and lactating women in North America. Am. J. Clin. Nutr. 89, 663S\u2013667S (2009).", "ArticleIdList": ["PMC2647760", "19073789"]}, {"Citation": "De Abrew, K. et al Grouping 34 chemicals based on mode of action using connectivity mapping. Toxicol. Sci. 151, 447\u2013461 (2016).", "ArticleIdList": ["27026708"]}, {"Citation": "Bowes, J. et al Reducing safety\u2010related drug attrition: the use of in vitro pharmacological profiling. Nat. Rev. Drug Discov. 11, 909\u2013922 (2012).", "ArticleIdList": ["23197038"]}, {"Citation": "Rietjens, I. , Slob, W. , Galli, C. & Silano, V. Risk assessment of botanicals and botanical preparations intended for use in food and food supplements: emerging issues. Toxicol. Lett. 180, 131\u2013136 (2008).", "ArticleIdList": ["18602975"]}]}], "History": [{"Year": "2018", "Month": "4", "Day": "5"}, {"Year": "2018", "Month": "5", "Day": "23"}, {"Year": "2018", "Month": "6", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "8", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "6", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "8"}], "PublicationStatus": "ppublish", "ArticleIdList": ["29882956", "PMC6175063", "10.1002/cpt.1132"]}}]}